NDC 81196-002 - vetality
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81196-002
- Package NDCs from labels
- 81196-002-01
- Manufacturer
- Tevra Brands LLC | ABS Corporation | Shandong Xinhua Pharmaceutical Co., Ltd.
- Effective date
- 2021-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| vetality ® | Tevra Brands LLC | ABS Corporation | Shandong Xinhua Pharmaceutical Co., Ltd. | 2021-01-15 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81196-002-01 | vetality | 1 in 1 BOX | TABLET, CHEWABLE | 1 | 1 | |
| 81196-002-01 | vetality | 120 in 1 BOTTLE | TABLET, CHEWABLE | 120 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | AAA PHARMACEUTICAL, INC. | f9c9a0b4-dbfe-7da9-e053-6294a90a7e09 | 2023-05-03 | Warnings | R16CO5Y76E |
| DG Health migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, LLC | d0e82cac-dfbb-49cb-99c8-560b02fb1a8c | 2023-04-05 | Warnings | R16CO5Y76E |
| basic care migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amazon.com Services LLC | edcc7b4b-1317-4060-b947-8c16effc5742 | 2023-02-27 | Warnings | R16CO5Y76E |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | XF417D3PSL |
| Aspirin Enteric Coated | ASPIRIN 81 MG | Lodaat LLC | 04017bc9-602a-4204-96a9-b7f9713155f6 | 2023-01-31 | Warnings | R16CO5Y76E |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | FSA STORE INC. | ec6b7017-cf12-09a7-e053-2995a90a2db9 | 2023-01-12 | Warnings | R16CO5Y76E |
| CitriPlus | JUGLANS REGIA WHOLE AND ANHYDROUS CITRIC ACID | PEKANA Natuheilmittel GmbH | 11db1b5b-2959-42c4-a059-25c951933004 | 2023-01-11 | Warnings | XF417D3PSL |
| Glucoreg | ASCORBICUM ACIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, DHEA (DEHYDROEPIANDROSTERONE), PHLORIDZINUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-LIPOICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, NADIDUM, PANTOTHENIC ACID, ACETALDEHYDE, INSULINUM (SUIS), INSULINUM (HUMAN), HEPAR SUIS, PANCREAS SUIS, PHLORIDZINUM, BARYTA OXALICA, ALLOXANUM, BERBERIS VULGARIS, CARCINOSIN, LYCOPODIUM CLAVATUM, MOMORDICA BALSAMINA, PHOSPHORICUM ACIDUM, PHOSPHORUS, | Deseret Biologicals, Inc. | 5117f980-95b8-4fc8-9425-8f6f05639437 | 2022-12-29 | Warnings | XF417D3PSL |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | XF417D3PSL | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | XF417D3PSL | |
| basic care migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amazon.com Services LLC | a19798b3-1b2e-4e4f-b595-2a156bd52ee5 | 2022-07-28 | Warnings | R16CO5Y76E |
| Aspirin 325 mg | ASPIRIN | WALGREENS | d71a22e8-9e39-a672-e053-2a95a90a1403 | 2022-07-08 | Warnings | R16CO5Y76E |
| topcare migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Topco Associates LLC | 9163ecfe-6493-46eb-a08d-b4134d84b0ab | 2022-06-28 | Warnings | R16CO5Y76E |
| dg health migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp Inc | 673d42d8-b484-4232-bc91-19d83db63550 | 2022-06-07 | Warnings | R16CO5Y76E |
| aspirin | ASPIRIN | Padagis US LLC | cce244aa-cd79-49c8-b68e-267f2bd0ef67 | 2022-04-30 | Warnings | R16CO5Y76E |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL | |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | d763511e-f1a7-4014-94b9-f7ad8f023ff4 | 2021-12-02 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | cf9f43a0-c750-4cf0-ac49-176ab2105aab | 2021-12-02 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.